Future prospects for anti-cytokine treatment.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 11053102.
- Also identified by PMC identifier 1766620.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The era of anti-cytokine treatment in rheumatology has just begun. The first generation therapeutic agents, biological agents that block tumour necrosis factor alpha such as monoclonal antibodies or receptor Ig fusion proteins are safe and effective, and so this has generated much interest in how to increase the benefit or deliver it more cost effectively. This article provides a personal view of the coming trends in anti-cytokine treatment. Which of these will be realised in the future will be of interest.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Cytokines